Clinical trialNCT01728051No, longer, availableExpanded Access

Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver

SponsorDelcath Systems Inc.Cutaneous MelanomaMetastatic Liver CancerOcular Melanoma

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The safety and efficacy of CS-PHP-melphalan has been evaluated in a phase 3 trial conducted in the same patient population as well as using the same melphalan dosing as proposed in this study. This expanded access protocol will provide an experimental alternative treatment option for both physicians and patients until the Delcath CS-PHP System receives marketing approval.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Charles W Nutting, DO
Sky Ridge Medical Center
Principal Investigator
clinicaltrials.gov ↗
Eric D Whitman, MD
Carol G. Simon Cancer Center at Morristown Memorial Hospital
Principal Investigator
clinicaltrials.gov ↗
H. Richard Alexander, MD
University of Maryland, Baltimore
Principal Investigator
clinicaltrials.gov ↗
James F Pingpank, MD
Univeristy of Pittsburg Cancer Center
Principal Investigator
clinicaltrials.gov ↗
Jonathan Zager, MD
H. Lee Moffitt Cancer Center and Research Institue at University of Southern Florida
Principal Investigator
clinicaltrials.gov ↗
Mark Faries, MD
Saint John's Cancer Institute
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

John Wayne Cancer Institute at Saint John'S Health Center
Santa Monica, California, United States
Sky Ridge Medical Center
Englewood, Colorado, United States
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
Tampa, Florida, United States
University of Maryland Medical Center
Baltimore, Maryland, United States
Carol G. Simon Cancer Center at Morristown Memorial Hospital
Morristown, New Jersey, United States
University of Pittsburg Cancer Institute
Pittsburgh, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Melphalan →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: —
Primary completion: —
Completion: —
Last update posted: 23 Oct 2013
Registered enrollment: —
Registry id: NCT01728051

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.